Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-17-005720
Filing Date
2017-06-19
Accepted
2017-06-16 17:45:42
Documents
13

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 2411371
2 GRAPHIC g407559g10q36.jpg GRAPHIC 88982
3 GRAPHIC g407559g29y33.jpg GRAPHIC 138423
4 GRAPHIC g407559g30i60.jpg GRAPHIC 104714
5 GRAPHIC g407559g37k67.jpg GRAPHIC 122591
6 GRAPHIC g407559g38h83.jpg GRAPHIC 44007
7 GRAPHIC g407559g40w11.jpg GRAPHIC 107501
8 GRAPHIC g407559g52v95.jpg GRAPHIC 55697
9 GRAPHIC g407559g55s41.jpg GRAPHIC 162989
10 GRAPHIC g407559g64o58.jpg GRAPHIC 139970
11 GRAPHIC g407559g66n68.jpg GRAPHIC 44409
12 GRAPHIC g407559g72k11.jpg GRAPHIC 36000
13 GRAPHIC g407559g89j19.jpg GRAPHIC 82797
  Complete submission text file 0000950123-17-005720.txt   3967062
Mailing Address TECHNOLOGIEPARK 21 ZWIJNAARDE GHENT C9 9052
Business Address TECHNOLOGIEPARK 21 ZWIJNAARDE GHENT C9 9052 003292620000
Ablynx NV (Filer) CIK: 0001617582 (see all company filings)

EIN.: 000000000 | State of Incorp.: C9 | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-01598 | Film No.: 17917044
SIC: 2836 Biological Products, (No Diagnostic Substances)